TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Biopharmacon, AB
Closing information (x1000 NOK)
| Closing information | 2024/06 | 2023/06 | 2022/06 |
| Turnover |
482
|
378
|
236 |
| Financial expenses |
5
|
0
|
59 |
| Earnings before taxes |
226
|
21
|
1,990 |
| EBITDA |
62
|
-35
|
16 |
| Total assets |
7,098
|
6,742
|
6,583 |
| Current assets |
6,681
|
6,325
|
6,175 |
| Current liabilities |
167
|
85
|
65 |
| Equity capital |
6,848
|
6,586
|
6,435 |
| - share capital |
100
|
99
|
97 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2024/06 | 2023/06 | 2022/06 |
| Solvency |
96.5%
|
97.7%
|
97.8% |
| Turnover per employee |
482
|
378
|
236 |
| Profit as a percentage of turnover |
46.9%
|
5.6%
|
843.2% |
| Return on assets (ROA) |
3.3%
|
0.3%
|
31.1% |
| Current ratio |
4000.6%
|
7441.2%
|
9500% |
| Return on equity (ROE) |
3.3%
|
0.3%
|
30.9% |
| Change turnover |
98
|
138
|
-163 |
| Change turnover % |
26%
|
57%
|
-41% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/06 | 2023/06 | 2022/06 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.